|
|
| (6 intermediate revisions by 3 users not shown) |
| Line 1: |
Line 1: |
| − | {{group
| + | #REDIRECT[[Roche]] |
| − | |wikipedia=https://en.wikipedia.org/wiki/Hoffmann-La_Roche
| |
| − | |constitutes=Big pharma
| |
| − | |leaders=
| |
| − | |logo=Roche.svg
| |
| − | |twitter=
| |
| − | |start=1896
| |
| − | |founders=Fritz Hoffmann-La Roche
| |
| − | |headquarters=
| |
| − | }}
| |
| − | | |
| − | ==nCoV-2019 antibody test==
| |
| − | Mai, 2020: The test is the third granted ''emergency approval by the [[FDA]]'' in a urgent procedure and the first commercially available. It gives quick results (18 Min.) and will be accepted worldwide in what has been touted one of Roche's biggest deals. <ref>
| |
| − | https://www.marketwatch.com/story/roche-coronavirus-test-gets-emergency-fda-approval-2020-03-13
| |
| − | </ref>
| |
| − | The test is not based on the PCR method (which directly detects parts of viral RNA) but addresses antibodies built by the immune system after 1-2 weeks of contact. These may not be specific with a risk for false positives stemming from common cold viruses. The test is self-approved by Roche with the FDA merely giving green light. <ref>
| |
| − | https://www.deutsche-apotheker-zeitung.de/news/artikel/2020/04/14/antikoerpertests-auf-corona-risiko-von-fehlinterpretation
| |
| − | </ref>
| |
| − | | |
| − | {{SMWDocs}}
| |
| − | ==References==
| |
| − | {{reflist}}
| |
| − | {{Stub}}
| |
